Guyana vs Mauritania: Incidence of tuberculosis
Incidence of tuberculosis over time
- Guyana
- Mauritania
How they compare
Guyana currently reports 67 per 100,000 people against 65 per 100,000 people in Mauritania, a difference of 2 per 100,000 people.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Mauritania ahead.
Guyana ranks 73rd and Mauritania ranks 76th of 208 countries.
Across the 3 decades both report, Guyana averaged higher in 1 and Mauritania in 2.
Head to head by decade
| Decade | Guyana | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 153.2 per 100,000 people | 196 per 100,000 people | 42.8 per 100,000 people | Mauritania |
| 2010s | 113.1 per 100,000 people | 112.4 per 100,000 people | 0.7 per 100,000 people | Guyana |
| 2020s | 63.8 per 100,000 people | 74.6 per 100,000 people | 10.8 per 100,000 people | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Guyana or Mauritania?
- Guyana, at 67 per 100,000 people against 65 per 100,000 people in Mauritania as of 2024.
- What is the difference in incidence of tuberculosis between Guyana and Mauritania?
- 2 per 100,000 people, with Guyana ahead.
- How many years of comparable data are there for Guyana and Mauritania?
- 25 years are reported by both, from 2000 to 2024.
- How do Guyana and Mauritania rank globally for incidence of tuberculosis?
- Guyana ranks 73rd and Mauritania ranks 76th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.